These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36161584)

  • 41. A Case of Atopic Dermatitis with High Serum Levels of Anti-BP180 Antibody and Dyshidrosiform Blisters Limited to the Palms and Soles.
    Kaisho J; Honda T; Dainichi T; Kabashima K
    Acta Derm Venereol; 2021 Mar; 101(3):adv00411. PubMed ID: 33606035
    [No Abstract]   [Full Text] [Related]  

  • 42. Bullous pemphigoid and dermatitis herpetiformis: mixed bullous disease or coexistence of two separate entities?
    Sander HM; Utz MM; Peters MS
    J Cutan Pathol; 1989 Dec; 16(6):370-4. PubMed ID: 2693505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pathology of the glycocalyx--possible cause of bullous and cicatricial pemphigoid].
    Mashkilleĭson AL; Golousenko IIu
    Vestn Dermatol Venerol; 1984 Jun; (6):12-5. PubMed ID: 6382857
    [No Abstract]   [Full Text] [Related]  

  • 44. Calcitriol exerts anti-inflammatory effects in keratinocytes treated with autoantibodies from a patient with bullous pemphigoid.
    Tukaj S; Grüner D; Tukaj C; Zillikens D; Kasperkiewicz M
    J Eur Acad Dermatol Venereol; 2016 Feb; 30(2):288-92. PubMed ID: 25610950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunoadsorption in dermatology].
    Hübner F; Kasperkiewicz M; Zillikens D; Schmidt E
    Hautarzt; 2019 Jan; 70(1):51-63. PubMed ID: 30519749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients.
    Chiorean RM; Baican A; Mustafa MB; Lischka A; Leucuta DC; Feldrihan V; Hertl M; Sitaru C
    Front Immunol; 2018; 9():2687. PubMed ID: 30524436
    [No Abstract]   [Full Text] [Related]  

  • 47. Characteristics of IgG subclasses and complement deposition in BP230-type bullous pemphigoid.
    Zheng M; Ujiie H; Iwata H; Muramatsu K; Yoshimoto N; Ito T; Ujiie I; Shimizu S; Sato-Matsumura KC; Shimizu H
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):595-600. PubMed ID: 30394605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular cloning of canine bullous pemphigoid antigen 2 cDNA and immunomapping of NC16A domain by canine bullous pemphigoid autoantibodies.
    Xu L; O'Toole EA; Olivry T; Hernandez C; Peng J; Chen M; Chan LS
    Biochim Biophys Acta; 2000 Jan; 1500(1):97-107. PubMed ID: 10564722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Detection of IgG autoantibodies in the sera of patients with bullous and gestational pemphigoid: ELISA studies utilizing a baculovirus-encoded form of bullous pemphigoid antigen 2.
    Haase C; Büdinger L; Borradori L; Yee C; Merk HF; Yancey K; Hertl M
    J Invest Dermatol; 1998 Mar; 110(3):282-6. PubMed ID: 9506450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association between bullous pemphigoid and atopic dermatitis: a population-based case-control study in Taiwan.
    Wu PC; Wu CY; Lyu YS; Chang YT; Wu CY
    Arch Dermatol Res; 2023 Apr; 315(3):419-427. PubMed ID: 35834038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis.
    Kamiya K; Aoyama Y; Nishio E; Horio A; Tokura Y
    J Dermatol; 2016 Sep; 43(9):1102-3. PubMed ID: 26946485
    [No Abstract]   [Full Text] [Related]  

  • 52. Does Adam17 cause the destruction of anchoring fibers via shedding tumor necrosis factor α in bullous pemphigoid and dermatitis herpetiformis?
    Zebrowska A; Wagrowska-Danilewicz M; Danilewicz M; Sokolowska M; Stasikowska-Kawecka O; Erkiert-Polguj A; Cynkier A; Pawliczak R; Sysa-Jedrzejowska A; Waszczykowska E
    J Cutan Med Surg; 2012; 16(3):149-50. PubMed ID: 22713436
    [No Abstract]   [Full Text] [Related]  

  • 53. The existence of a platelet-activating factor (Paf-acether)-like substance in blister fluid derived from patients with bullous pemphigoid as demonstrated by human platelet aggregation techniques.
    Okubo K; Karashima T; Hachisuka H; Sasai Y
    Kurume Med J; 1989; 36(4):173-9. PubMed ID: 2700767
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
    Brooks WS; Lee YY; Abell E; Deng JS
    J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
    Julio T; Vernal S; Turatti A; Roselino AM
    Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
    [No Abstract]   [Full Text] [Related]  

  • 56. [Evaluation of histological criteria for bullous pemphigoid. Correlation with antigens recognized by immunoblotting of anti-epidermal autoantibodies].
    Courville P; Kupfer I; Gilbert D; Thomine E; Metayer J; Joly P
    Ann Pathol; 2000 Dec; 20(6):564-9. PubMed ID: 11148352
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?
    Salmhofer W; Kawahara Y; Soyer HP; Kerl H; Nishikawa T; Hashimoto T
    Br J Dermatol; 1997 Oct; 137(4):599-604. PubMed ID: 9390339
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Linear IgA bullous dermatosis in children with autoantibodies against 180 kDa pemphigoid antigen].
    Bérard F; Kanitakis J; Di Maio M; Ghohestani R; Hermier C; David L; Claudy A; Faure M
    Arch Pediatr; 1996 Apr; 3(4):345-7. PubMed ID: 8762956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pemphigoid vegetans represents a bullous pemphigoid variant. Patient's IgG autoantibodies identify the major bullous pemphigoid antigen.
    Chan LS; Dorman MA; Agha A; Suzuki T; Cooper KD; Hashimoto K
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):331-5. PubMed ID: 8436652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies.
    Zillikens D; Rose PA; Balding SD; Liu Z; Olague-Marchan M; Diaz LA; Giudice GJ
    J Invest Dermatol; 1997 Oct; 109(4):573-9. PubMed ID: 9326393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.